chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Thirty minutes after receiving the vaccination I experienced numbness in my face, neck, and upper arms on both sides. When I would talk I could feel the numbness in my lips and in my face from making the movement of talking. When moving my arms I could also feel this same paralysis or numbness feeling. I monitored my symptoms and they started to fade the following day in the evening.
Vaccine: 12/30/2020 0900 AM Symptoms started: 12/30/2020 0925 AM Symptoms: tachycardia 150s, weakness, feeling extremely hot, lip and facial numbness, tightness on throat, difficulty swallowing, shortness of breath  Duration: 1 hour  Frequency post vaccination: QDAY but less severe  ED Visit: 12/31/2020 prescribed Zyrtec and Pepcid  Symptoms still occurring going on week two post vaccination
neck was red; face was red; forehead was red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included TICAGRELOR (BRILINTA), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ROSUVASTATIN, METOPROLOL, RAMIPRIL and VITAMIN D3 for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 05-Feb-2021 at a dose of UNK dosage form and PREDNISONE on 05-Feb-2021 at a dose of UNK dosage form. On 05-Feb-2021, ERYTHEMA (neck was red), ERYTHEMA (face was red) and ERYTHEMA (forehead was red) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No treatment information was reported.
This non-serious spontaneous case, initially received on 20-Dec-2017, was reported by other health professional and concerns a 34-year-old female adult pregnant patient of weight: 165 pounds and height: 64 inches. The patient had history of spontaneous abortion. The patient's LMP (last menstrual period) was reported as 15-May-2017. The patient's current condition included Down's syndrome (screened positive for increased risk of Down syndrome). The patient's concomitant medication included VITAFOL-ONE. The patient had no family history of congenital malformations. It was reported that the patient did not use tobacco, alcohol or illicit drug. On 04-Aug-2017, the cystic fibrosis mutation analysis was normal with no major congenital malformations. On 08-Aug-2017, first trimester screen and panorama showed normal result with no major congenital malformations. On 28-Aug-2017, second trimester screen was positive for increased risk of Down syndrome. On 25-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (batch number: 00644623A (as reported), dose, route of administration, anatomical location, expiry date: not reported) at 19 weeks of gestation period (singleton pregnancy) (explicitly considered as vaccine exposure during pregnancy). At the time of the report the outcome was not reported. The CEDD (expected date of delivery) was reported as 19-Feb-2018.
Severe loss of subcutaneous fat, discoloration and atrophy of surface skin. Continuous bleeding and large area-size of a quarter-of blood colored skin with very fragile surface. Easily broken and very depressed.
Patient passed out,felt down , unconscious ,he was pale, had  pulse.  We  called emergency I kept talking to patient and wake him up till the ambulance arrived.  I called him after few hours to check on him
48 patients received an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine). On 15-Nov-2021, EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter stated that they had just received the vaccine on 18-OCT-2021 and did not realize it expired 07-NOV-2021.The vial was initially stored in the refrigerator on 18-OCT-21 and vial didn't undergo any temperature excursions. When reporter was providing information, she realized one patient had not received a Moderna vaccine. So the total number reported was 47.  No concomitant medication details was provided. No treatment medication details was provided.
Pt  history of tingly hands about a month after vaccinations. Mother allergic to flu vaccines.  March 16: rash break outs. Tingling feet & hands. March 28: sudden paralysis of legs while walking. Loss of bladder control. Symptoms increased over next 2 weeks to life threatening paralysis. Pt sheltered in place since early March afraid of exposure to coronavirus and afraid of ventilators. Said goodbye to family and friends. Current: spinal pain & inflammation at T12 and L1.  A magnet collected a visible clump of metal in vein near wrist. Possibly from accumulation of vaccines.
After R administration - MENACTRA, loss of consciousness, returned with feet elevation no distress. Respirations none labored. AO x 3, pulse strong 80, R - 16, BP 110/70. Skin warm and dry.
Red, pinpoint rash to arms, legs, back at different stages of development noted in office 06/4/02. Approximately 5-10 lesions diagnosed by MD as vaccine reaction to varicella. There had been zero noted exposure to varicella. Treatment - Tylenol.
This is a spontaneous report from a non-contactable consumer who reported for him/her self. A patient of unspecified age race and gender received PREVNAR 13, via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported.  The patient had a reaction from the vaccine on an unspecified date with outcome of unknown. No follow-up attempts possible. No further information expected.
Moderna vaccine (first dose) was given in error to a patient who is 15 years old. Clinic was contacted with error information. Provider contacted patient/mother and explained the error. Patient is reportedly doing  fine. No adverse events.
received this as a second dose received first dose 4/30/21 Moderna lot #043B21A
Soreness and slight rash at area of injection for 3 days. Then symptoms subsided & disappeared. Severe general muscle soreness in legs and arms for 3 days. Then symptoms subsided & disappeared.
Approximately at 1am the morning after I received the rsv vaccine I became extremely cold and couldn't stop shaking .    This lasted for about 20 minutes.  Around 10 am I felt warm and thermometer showed 100.3.  There was a large knot at injection site and arm was red and felt hot to touch.  I also had a severe headache.  These symptoms lasted for approximately 24 hours.  Headache remained for approximately 48 hours and as of today 9/12/23 injection site is still slightly red and sore but other symptoms are gone.
The patient received the third/booster dose of BNT162b2; Swollen arm; Sore arm; Continued swelling and lump at injection site; Lump at injection site; Still lump in injection area and some soreness; I started spotting as well days before my menstrual cycle should be coming on; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 02Nov2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included HBP (high blood pressure) diagnosed in Jun2021. The patient had known allergies to several food products: apples, strawberries and other products noted in allergy tests in past. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), ethinylestradiol/ferrous fumarate/norethisterone acetate (JUNEL FE), fluticasone propionate (FLONASE) and loratadine (OTC CLARITIN) all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246) via an unspecified route of administration in the left arm on 13Jan2021 (at the age of 43-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 03Feb2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Nov2021, the patient experienced swollen and sore arm a day or two after shot and continued swelling and lump at injection site several days later into weekend. Still lump in injection area and some soreness. The patient started spotting as well days before her menstrual cycle should be coming on and that was the main reason the patient was submitting this information. The patient believed this booster had in some way contributed to the spotting prior to the official start date of when period should start (the patient was on birth control and usually did not have spotting or early start issues). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen and sore arm, continued swelling and lump at injection site, still lump in injection area and some soreness and spotting as well days before her menstrual cycle were resolving at the time of this report.
Within 1 day a local reaction and progressed to cellulitis the day after. Treated with antibiotics - clindamycin 300mg TID.
patient become warm, sweaty and unresponsive while seated. the patient was placed on the ground and was kept there for 10 minutes until first responders arrived to the scene.
Patient reports having a sore arm that is warm to the touch after getting her second Pfizer COVID-19 vaccine. She also reports some continued soreness and itchy feeling in her left arm which is about the size of a hand. She reports that this adverse reaction has improved since it started on 6/23/21 but it is still present ~5 days later. She will continue to monitor, and will report back to us and her primary care physician.
Patient is in 3rd trimester of pregnancy. She developed shortness of breath, chest pains,  nausea/ vomiting,, and headache the night of 2nd vaccination. She took acetaminophen that night, and her headache dissipated marginally the following day. However, she still felt short of breath.
pt recvd vax & lost consciousness for 5 -10 sec; BP nl; responded immed to RN; over to sit & eat color returned in 5-10min; taken home;
Syncope- this pt actually passed out about 3 minutes after receiving the injection.  We had to use an ammonia inhalant to help her come to.
Bell's Palsy; I went to the ER because I couldn't feel my left side of my face; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200132291 (Pfizer).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Dec2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid" (unspecified if ongoing), notes: I was perfectly normal before I had Covid. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1; Manufacturer Unknown), for Covid-19 immunization. The following information was reported: BELL'S PALSY (medically significant) with onset 24Jan2022, outcome "unknown", described as "Bell's Palsy"; HYPOAESTHESIA (non-serious) with onset 24Jan2022, outcome "unknown", described as "I went to the ER because I couldn't feel my left side of my face". The events "bell's palsy" and "i went to the er because i couldn't feel my left side of my face" were evaluated at the emergency room visit.  Additional information: The patient was perfectly normal before patient had COVID and the Pfizer vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Swelling of immunization site to baseball size, (+) erythema, (+) warmth
Headache, Myalgia, Fever, CoughWheeze,  NauseaVomiting, congestion Narrative:
swollen throat; trouble breathing; weakness; body aches; chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness) and PAIN (body aches) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). On 08-Mar-2021, the patient experienced PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills). On 04-Mar-2021, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had resolved. At the time of the report, PHARYNGEAL SWELLING (swollen throat), DYSPNOEA (trouble breathing), ASTHENIA (weakness), PAIN (body aches) and CHILLS (chills) was resolving.            The patient took the second dose of the mRNA-1273, hence action taken with the vaccine in response to the events was not applicable.   No concomitant medication was reported.  No treatment medication was reported.
Syringe leaked and not sure how much Vaccine was administered; A spontaneous report was received from a pharmacist concerning a patient of unknown age who received Moderna's COVID-19 vaccine and experienced syringe leaked and not sure how much vaccine was administered.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 05 Jan 2021, a pharmacist reported that liquid leaked out of a syringe while the nurse was injecting and is not sure how much of the vaccine was applied to the patient. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The event, syringe leaked and not sure how much vaccine was administered, was considered resolved.; Reporter's Comments: This case concerns a patient who received their first of two planned doses of mRNA-1273 (Lot unknown, reporting syringe leaked  and not sure how much vaccine was administered without any associated adverse events.
Pain on right side of body; Fatigue; Headache; This case was received via  Medicines Agency (Reference number: 126972   ) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, PAIN (Pain on right side of body), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-278399 (Patient Link).
1/14/22  Pfizer COVID-19  vaccine administered in right thigh due to lack of upper extremities. No reaction during observation time after administration of vaccine, stayed with patient for 30 minutes due to extensive allergy list and possible immunocompromising illness. 2/09/22  I returned to the patient's home to administer the second dose of Pfizer COVID-19 vaccine, patient advised me that she had a "reaction" 3 days later. Upon discussion she described a local reaction at the injection site,  Knot under skin with some redness. She also stated that  2 days following this reaction she had hives all over her body.  We discussed consulting her physician before administering the 2nd dose. Hives had resolved at the time of my visit,  patient stated they resolved within 48 hours of  appearance.  Patient is scheduled with a new physician in one week.  RN
Swollen lymph nodes in arm pit area, I don't exact influenza strain vaccine given.
PATIENT EXPERIENCING SORENESS MORE THAN USUAL FEW HOURS AFTER INJECTION AND SORENESS REMAINED THE SAME UP TO TODAY.
This spontaneous prospective pregnancy report as received from a physician refers to a female patient of unknown age. Patient's concurrent conditions and relevant medical history was no reported. On an unknown date the patient was vaccinated with VARIVAX (Merck) (lot number, dose, frequency and route unspecified). Concomitant medications were not reported. On an unknown date, the patient was determined to be pregnant following vaccination. The patient was in her first trimester of pregnancy. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. The pregnancy outcome was outcome pending. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with VARIVAX (Merck) was not reported. Product quality issue was not involved. Additional information has been requested.
Itching - increased at injection site but also diffuse to legs - oral BENADRYL.
A report has been received from a Health Professional concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient received expired FLUMIST QUADRIVALENT that were two days expired. Patient have reported no adverse effects. The patient experienced sixteen patients received expired FLUMIST QUADRIVALENT which started on 15-Jan-2014. The outcome of the event of sixteen patients received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
local rxn @ site approx 13cm diameter; indurated with 7x7 cm area; also was itching;
Two hours after Td vaccine, pt evaluated by school nurse for hives on thighs, lower leg, arms. No respiratory distress. Seen in office with urticaria. Treated with Benadryl.
Not sure if it is related but wanted to report in case there is a trend  moving forward so that the research can be accurate.  I have crohns which has been in remission for years.  A week after the bivalent vaccine I am in a crohns flare up.  The night of the shot I had expected side effects including sore arm, pain in lymph node under arm, aches and pains, fever, chills, fatigue. This lasted through the night and into the next day then resolved.
Patient's boyfriend called over and stated she was reported feeling faint, lightheaded, dizzy, looked pale in the face and broke out into sweats and with cold clammy skin. I had her sit in head down position for several minutes and started to monitor her vitals. Prior to vaccine pt was having severe anxiety and has a history of syncope with blood drawns. After several mins of her sitting with ehr head down I checked her blood pressure and it was elevated 155/109 mmHg. 10 minutes later pt felt a little better but started to feel faint and dizzy again. I called emergency sevices and EMS arrived at the scene, assessed the patient and diagnosed her with anxiety/syncope. She opted out from going to the hospital with them. She left the store at 1:01 pm and felt alot better and stated she had an appt with her PCP at 3pm to further seek medical treatment if deemed necessary
day after second shot my arm broke out in a horrible rash from shoulder to hand..arm felt like it was broken and one fire..terrible pain for weeks rash lasted 3 weeks is going away..arm pain better but hand pain still there, no feeling in my fingertips and hand very sore and red
2 weeks after my 2nd vaccine, I suffered complete hearing loss in my left ear. The hearing loss began around 8 Am and by 3 PM the same day, I was 100% deaf in my ear.  I visited a walk in clinic and was told it was probably  from allergies which I do not have. I was given a steroid injection and additional medications and told I would be better within 48 hours. After 48 hours there was no improvement. I traveled to the medical facility and saw an ENT doctor, who sent me for a audiology test.
pt recv vax & the next day pt devel fever 100 & lymphadenitis of the axilla & neck;pt was treated w/advil;No further details were available @ the time of this report;
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 55-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Co-suspect products included TETANUS SHOT for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season and TETANUS SHOT. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent unspecified season and unknown after receiving TETANUS SHOT, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: Age at vaccination was not reported. The patient received an unspecified tetanus shot a few years ago and an unknown flu shot a few months ago and having a sore arm afterwards that lasted a day or two. The reporter did not consent to follow-up.  This case has been linked with the case US2020223100 reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020223100:same reporter
In approximately June 2000 the patient was vaccinated with varicella virus vaccine live. On 08/09/2000 the patient broke out in a full blown case of chicken pox, more than 50 lesions. It was reported that another patient has a similar reaction after exposure to varicella virus vaccine line. Unspecified medical attention was sought. Additional information has been requested.